Global Health Ltd
Global Health Ltd Share Price Today: Live Updates & Key Insights
Get insights on Global Health Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Global Health Ltd Share Price Chart
Global Health Ltd Fundamentals
Traded Volume: 2,31,535
Market Cap(Cr): 32,978
Avg Traded Price 1222.72
1 Year return 14.35%
Upper Circuit 1,229
Lower Circuit 1,212
P/E TTM 59.00
P/B Ratio 21.00
Traded Value(Cr) 2840.70
EPS TTM 20.899
Book value 20.899
Dividend 0.00%
Global Health Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Global Health Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Global Health Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W +2.09%
1M -11.38%
3M -10.97%
1Y +14.35%
YTD +10.21%
Global Health Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Global Health Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 1.56L
Day Before Yesterday 1.04L
1W Avg 2.06L
1M Avg 2.98L
3M Avg 2.83L
Global Health Ltd Technical Details
Global Health Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 1216
Support 2 1206
Support 3 1199
Pivot Point : 1223
Resistance 1 1233
Resistance 2 1240
Resistance 3 1250
Global Health Ltd Corporate Actions
Global Health Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Global Health Ltd’s capital allocation strategies.
All
Ex-Date 22-Aug-2025 Type D Description 0.50/share@25.00% Record Date 22-Aug-2025 Ratio 25.00
Dividends
Announcement Date 22-Aug-2025 Ex Dividend Date 22-Aug-2025 Dividend(%) 25
Bonus
No Bonus has been declared by MEDANTA
Splits
No Split has been declared by MEDANTA
Others
Rights No Rights has been declared by MEDANTA
Global Health Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Global Health Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Global Health Ltd's relative performance and valuation against major competitors.
Stock Name Fortis Healthcare Ltd ₹921.00 (-1.54%) M. Cap (Cr) 695.32 1 Yr Return (%) +35.30% P/E (TTM) 68.57 PB Ratio 8.86
Stock Name Narayana Hrudayalaya Ltd ₹2043.20 (+1.30%) M. Cap (Cr) 417.55 1 Yr Return (%) +62.29% P/E (TTM) 49.40 PB Ratio 13.03
Stock Name Aster DM Healthcare Ltd ₹650.20 (-2.27%) M. Cap (Cr) 336.88 1 Yr Return (%) +51.86% P/E (TTM) 101.68 PB Ratio 9.75
Stock Name Global Health Ltd ₹1226.90 (+1.14%) M. Cap (Cr) 329.78 1 Yr Return (%) +14.35% P/E (TTM) 58.70 PB Ratio 10.50
Stock Name Krishna Institute of Medical Sciences Ltd ₹670.10 (-0.44%) M. Cap (Cr) 268.13 1 Yr Return (%) +14.74% P/E (TTM) 79.80 PB Ratio 13.39
Stock Name Dr Agarwals Health Care Ltd ₹493.75 (-0.23%) M. Cap (Cr) 156.11 1 Yr Return (%) NaN% P/E (TTM) 136.16 PB Ratio 10.37
Stock Name Rainbow Childrens Medicare Ltd ₹1330.00 (-0.59%) M. Cap (Cr) 135.07 1 Yr Return (%) -15.49% P/E (TTM) 53.23 PB Ratio 10.05
Global Health Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Global Health Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2025 527.67 Mar 2024 340.64 Mar 2023 430.53 Mar 2022 235.40
PARTICULARS Investing Activities Mar 2025 -638.20 Mar 2024 -698.52 Mar 2023 -257.29 Mar 2022 -312.99
PARTICULARS Financing Activities Mar 2025 -94.49 Mar 2024 -66.23 Mar 2023 404.22 Mar 2022 97.59
PARTICULARS Net Cash Flow Mar 2025 -205.03 Mar 2024 -424.11 Mar 2023 577.47 Mar 2022 20.01
Global Health Ltd Shareholding Pattern
This shows the ownership breakdown of Global Health Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 33.01%
Public 42.56%
Other Institutions 1.14%
FII 11.41%
Mutual Funds 11.83%
About Global Health Ltd
Global Health Limited (GHL) was incorporated as `Global Health Private Limited' on August 13, 2004 at New Delhi, India as a Private Company. The status of the Company got converted into a Public Limited Company and the name was changed to `Global Health Limited' dated August 11, 2021 issued by the RoC. Presently, the Company is engaged in providing healthcare services.The Company was founded by Dr. Naresh Trehan, a world-renowned cardiovascular and cardiothoracic surgeon. The Company is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India in terms of bed capacity with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urologoly. Medanta currently operates 3,042 beds across its five major hospitals located in Gurugram, Lucknow, Patna, Indore, and Ranchi, serving key regions across northern and eastern India. Medanta Gurugram (1,440 beds), Lucknow (757 beds), and Patna (470 beds) are the largest single-location private hospitals in their respective states. Renowned for delivering advanced tertiary and quaternary care, the Medanta network includes over 700 ICU beds and more than 80 operating theatres.In November 2009, the Company opened its flagship hospital in Gurugram. In 2015, its subsidiary, Global Health Patliputra Private Limite (GHPPL), entered into a Concession Agreement with Governor of Bihar for the development, operation and maintenance of a proposed hospital on public-private partnership at Patna.In 2019, it commenced operations of new hospital at Lucknow.The Company has taken in-house facility and operate pharmacies at its Gurugram, Lucknow, Indore and Ranchi hospitals as well as launched an outpatient department pharmacy at South Delhi clinic in year 2021 and launched outpatient department pharmacy at South Delhi clinic at Patna hospital in year 2022. As at June 30, 2022, it had 200 installed beds and employed over 50 doctors across key specialties such as neuroscience and cardiac sciences. Patna hospital had 228 installed beds and employed over 125 doctors as at June 30, 2022 and is designed to accommodate over 500 beds. The Company came out with a public issue during November, 2022 by raising Rs. 2205.57 crores through fresh issue amounting to Rs. 500 crores and offer for sale amounting to Rs. 1705.57 crores.The Company's Lucknow hospital added 191 beds in FY23, including over 90 critical care beds. Lucknow Hospital further added 7 new OTs and have hired over 50 senior clinicians. Towards the end of FY 2023, Lucknow Hospital commissioned the Siemens Varian EDGE Radiation Oncology machine - the first in North India - as well as set up a dedicated e-ICU Command Centre to assist in remote critical care management. The Company's Patna hospital added over 100 beds and 35+ doctors in FY23. In FY23, the Company introduced a new 300- bed hospital project in Indore. It started Medanta Labs in January 2023. During the year 2022-23, GHL Pharma was incorporated as a wholly-owned subsidiary on June 29, 2022.Medanta launched its retail diagnostics business in January 2023. The Company added 126 new beds, including 98 beds in Lucknow in March 2024 and 28 at the Patna hospital. Additionally, 4 new operating theatres were inaugurated at the Patna facility to address the increasing demand for surgical procedures and critical care. These expansions brought the total bed capacity to 2,823 across 5 hospitals as of March 31, 2024. Company also strengthened its clinical capabilities by onboarding over 150 new senior clinicians throughout the year. A comprehensive Oncology Care service program was launched at both Lucknow and Patna, featuring the operationalization of the Varian Edge Linear Accelerator (Linac) machine for radiation oncology. Further, eight new specialities were introduced at Patna, and five new specialities were launched at Lucknow.In FY 2024-25, Medanta Holdings Private Limited, a wholly-owned subsidiary got merged with the Company, through the Scheme of Amalgamation, making it effective from April 01, 2024. In FY2025, the Company added 219 new beds across its network, representing a 7.8% increase in overall bed capacity.
Chairman / Executive Director / Managing Director
Naresh Kumar Trehan
Registered office Medanta-Mediclinic, E-18 Defence Colony, New Delhi, New Delhi, 110024
FAX :91-124-4834060
Background
Incorporation Year 2004
Face Value ₹2.00
Market Lot 1
FAQs on Global Health Ltd
How to buy Global Health Ltd shares on NSE?
To buy Global Health Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the Global Health Ltd share price today?
The Global Health Ltd share price on NSE is ₹1226.90 today.
What is the market cap of Global Health Ltd on NSE?
The company has a market capitalization of ₹32977.89.
What is the PE & PB ratio of Global Health Ltd?
PE is 59 and PB is 21.
What is the 52 Week High and Low of Global Health Ltd shares?
Global Health Ltd stock price high: ₹1456.50 Global Health Ltd stock price low: ₹996.45.